Platinum(II) as Bifunctional Linker in Antibody-Drug Conjugate Formation: Coupling of a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore to Trastuzumab as a Model

D.C.J. Waalboer; J.A. Muns; N.J. Sijbrandi; R.B.M. Schasfoort; R. Haselberg; G.W. Somsen; H.J. Houthoff; G.A.M.S. van Dongen

doi:https://doi.org/10.1002/cmdc.201402496

Platinum(II) as Bifunctional Linker in Antibody-Drug Conjugate Formation: Coupling of a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore to Trastuzumab as a Model

D.C.J. Waalboer, J.A. Muns, N.J. Sijbrandi, R.B.M. Schasfoort, R. Haselberg, G.W. Somsen, H.J. Houthoff, G.A.M.S. van Dongen

Radiology and Nuclear Medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

Abstract

The potential of platinum(II) as a bifunctional linker in the coordination of small molecules, such as imaging agents or (cytotoxic) drugs, to monoclonal antibodies (mAbs) was investigated with a 4-nitrobenzo-2-oxa-1,3-diazole (NBD) fluorophore and trastuzumab (Herceptin™) as a model antibody. The effect of ligand and reaction conditions on conjugation efficiency was explored for [Pt(en)(L-NBD)Cl](NO

Original language	English
Pages (from-to)	797-803
Journal	CHEMMEDCHEM
Volume	10
Issue number	5
DOIs	https://doi.org/10.1002/cmdc.201402496
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.1002/cmdc.201402496

Cite this

Waalboer, D. C. J., Muns, J. A., Sijbrandi, N. J., Schasfoort, R. B. M., Haselberg, R., Somsen, G. W., Houthoff, H. J., & van Dongen, G. A. M. S. (2015). Platinum(II) as Bifunctional Linker in Antibody-Drug Conjugate Formation: Coupling of a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore to Trastuzumab as a Model. CHEMMEDCHEM, 10(5), 797-803. https://doi.org/10.1002/cmdc.201402496

@article{8544cbd25a9f44d2a42851668324a045,

title = "Platinum(II) as Bifunctional Linker in Antibody-Drug Conjugate Formation: Coupling of a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore to Trastuzumab as a Model",

abstract = "The potential of platinum(II) as a bifunctional linker in the coordination of small molecules, such as imaging agents or (cytotoxic) drugs, to monoclonal antibodies (mAbs) was investigated with a 4-nitrobenzo-2-oxa-1,3-diazole (NBD) fluorophore and trastuzumab (Herceptin{\texttrademark}) as a model antibody. The effect of ligand and reaction conditions on conjugation efficiency was explored for [Pt(en)(L-NBD)Cl](NO",

author = "D.C.J. Waalboer and J.A. Muns and N.J. Sijbrandi and R.B.M. Schasfoort and R. Haselberg and G.W. Somsen and H.J. Houthoff and {van Dongen}, G.A.M.S.",

year = "2015",

doi = "https://doi.org/10.1002/cmdc.201402496",

language = "English",

volume = "10",

pages = "797--803",

journal = "CHEMMEDCHEM",

issn = "1860-7179",

publisher = "John Wiley and Sons Ltd",

number = "5",

}

TY - JOUR

T1 - Platinum(II) as Bifunctional Linker in Antibody-Drug Conjugate Formation: Coupling of a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore to Trastuzumab as a Model

AU - Waalboer, D.C.J.

AU - Muns, J.A.

AU - Sijbrandi, N.J.

AU - Schasfoort, R.B.M.

AU - Haselberg, R.

AU - Somsen, G.W.

AU - Houthoff, H.J.

AU - van Dongen, G.A.M.S.

PY - 2015

Y1 - 2015

N2 - The potential of platinum(II) as a bifunctional linker in the coordination of small molecules, such as imaging agents or (cytotoxic) drugs, to monoclonal antibodies (mAbs) was investigated with a 4-nitrobenzo-2-oxa-1,3-diazole (NBD) fluorophore and trastuzumab (Herceptin™) as a model antibody. The effect of ligand and reaction conditions on conjugation efficiency was explored for [Pt(en)(L-NBD)Cl](NO

AB - The potential of platinum(II) as a bifunctional linker in the coordination of small molecules, such as imaging agents or (cytotoxic) drugs, to monoclonal antibodies (mAbs) was investigated with a 4-nitrobenzo-2-oxa-1,3-diazole (NBD) fluorophore and trastuzumab (Herceptin™) as a model antibody. The effect of ligand and reaction conditions on conjugation efficiency was explored for [Pt(en)(L-NBD)Cl](NO

U2 - https://doi.org/10.1002/cmdc.201402496

DO - https://doi.org/10.1002/cmdc.201402496

M3 - Article

C2 - 25809281

SN - 1860-7179

VL - 10

SP - 797

EP - 803

JO - CHEMMEDCHEM

JF - CHEMMEDCHEM

IS - 5

ER -